Skip to main content

Long-term efficacy of ‘ready-to-drink’ protein substitute in phenylketonuria

Buy Article:

$43.00 plus tax (Refund Policy)

Abstract Background: 

In phenylketonuria (PKU), protein substitute is an essential part of dietary treatment. Short-term studies have demonstrated that liquid protein substitutes (LPS) are efficacious, and improve compliance in teenagers and adults with PKU, although there are no data available to demonstrate that their effectiveness is sustained over time. The present retrospective study aimed to evaluate the long-term efficacy of ready-to-drink protein substitute in a group of people with PKU. Methods: 

Thirty-four patients (17 females and 17 males, median age 14.9 years, range 7.2–53.8 years) with PKU on dietary management were recruited from Birmingham Children’s Hospital. All patients who were taking a LPS for a median of 2.4 years (range 6 months to 4.1 years), had their plasma phenylalanine concentrations, anthropometric and nutritional biochemical markers reviewed, both before and when taking the LPS. Results: 

There was a significant improvement in median plasma phenylalanine (P < 0.05), vitamin B12 (P < 0.01), calcium (P < 0.05) and albumin (P < 0.05) concentrations in subjects (n = 13) aged >18 years when taking the LPS. In the children aged 7–18 years (n = 21), median plasma phenylalanine concentrations were maintained on LPS. Their plasma selenium concentrations (P < 0.05) deteriorated, but calcium (P < 0.05), albumin (P < 0.01), haemoglobin (P < 0.01) and haematocrit (P < 0.01) significantly improved. Conclusions: 

This retrospective review suggested that, in adult patients, the long-term use of LPS is associated with better compliance by lowering blood phenylalanine and improving nutritional biochemical markers.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: liquid protein substitutes; phenylalanine; phenylketonuria

Document Type: Research Article

Affiliations: 1: Birmingham Children’s Hospital, Birmingham, UK 2: Clinical Chemistry Department, Birmingham Children’s Hospital NHS Trust, Birmingham, UK 3: University Hospitals Birmingham NHS Foundation Trust, Selly Oak Hospital, Birmingham, UK 4: Department of Inherited Metabolic Disorders, Birmingham Children’s Hospital NHS Trust, Birmingham, UK

Publication date: 2009-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more